Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 31


DNA vaccines, electroporation and their applications in cancer treatment.

Lee SH, Danishmalik SN, Sin JI.

Hum Vaccin Immunother. 2015;11(8):1889-900. doi: 10.1080/21645515.2015.1035502.


Biomarkers for glioma immunotherapy: the next generation.

Sims JS, Ung TH, Neira JA, Canoll P, Bruce JN.

J Neurooncol. 2015 Jul;123(3):359-72. doi: 10.1007/s11060-015-1746-9. Epub 2015 Feb 28.


DNA vaccine for cancer immunotherapy.

Yang B, Jeang J, Yang A, Wu TC, Hung CF.

Hum Vaccin Immunother. 2014;10(11):3153-64. doi: 10.4161/21645515.2014.980686. Review.


Combination of alphavirus replicon particle-based vaccination with immunomodulatory antibodies: therapeutic activity in the B16 melanoma mouse model and immune correlates.

Avogadri F, Zappasodi R, Yang A, Budhu S, Malandro N, Hirschhorn-Cymerman D, Tiwari S, Maughan MF, Olmsted R, Wolchok JD, Merghoub T.

Cancer Immunol Res. 2014 May;2(5):448-58. doi: 10.1158/2326-6066.CIR-13-0220. Epub 2014 Feb 26.


DNA Vaccines for Prostate Cancer.

McNeel DG, Becker JT, Johnson LE, Olson BM.

Curr Cancer Ther Rev. 2012 Nov 1;8(4):254-263.


Anti-cytotoxic T lymphocyte antigen-4 antibodies in melanoma.

Tosti G, Cocorocchio E, Pennacchioli E.

Clin Cosmet Investig Dermatol. 2013 Oct 17;6:245-56. doi: 10.2147/CCID.S24246. Review.


Sipuleucel-T: immunotherapy for advanced prostate cancer.

Olson BM, McNeel DG.

Open Access J Urol. 2011 May 3;3:49-60. doi: 10.2147/OAJU.S13069. Review.


Use of ipilimumab in the treatment of melanoma.

Acharya UH, Jeter JM.

Clin Pharmacol. 2013 Aug 9;5(Suppl 1):21-7. doi: 10.2147/CPAA.S45884. Review.


Synergistic effect of CTLA-4 blockade and cancer chemotherapy in the induction of anti-tumor immunity.

Lesterhuis WJ, Salmons J, Nowak AK, Rozali EN, Khong A, Dick IM, Harken JA, Robinson BW, Lake RA.

PLoS One. 2013 Apr 23;8(4):e61895. doi: 10.1371/journal.pone.0061895. Print 2013.


Modulation of tumor immunity by soluble and membrane-bound molecules at the immunological synapse.

González PA, Carreño LJ, Céspedes PF, Bueno SM, Riedel CA, Kalergis AM.

Clin Dev Immunol. 2013;2013:450291. doi: 10.1155/2013/450291. Epub 2013 Mar 7. Review.


Immunomodulatory therapy for melanoma: ipilimumab and beyond.

Callahan MK, Postow MA, Wolchok JD.

Clin Dermatol. 2013 Mar-Apr;31(2):191-9. doi: 10.1016/j.clindermatol.2012.08.006. Review.


Human prostate tumor antigen-specific CD8+ regulatory T cells are inhibited by CTLA-4 or IL-35 blockade.

Olson BM, Jankowska-Gan E, Becker JT, Vignali DA, Burlingham WJ, McNeel DG.

J Immunol. 2012 Dec 15;189(12):5590-601. doi: 10.4049/jimmunol.1201744. Epub 2012 Nov 14.


Ipilimumab pharmacotherapy in patients with metastatic melanoma.

Jeter JM, Cranmer LD, Hersh EM.

Clin Med Insights Oncol. 2012;6:275-86. doi: 10.4137/CMO.S7245. Epub 2012 Jul 30.


Targeting costimulatory molecules to improve antitumor immunity.

Capece D, Verzella D, Fischietti M, Zazzeroni F, Alesse E.

J Biomed Biotechnol. 2012;2012:926321. doi: 10.1155/2012/926321. Epub 2012 Feb 12. Review.


Blockade of cytotoxic T-lymphocyte antigen-4 as a new therapeutic approach for advanced melanoma.

Wang XY, Zuo D, Sarkar D, Fisher PB.

Expert Opin Pharmacother. 2011 Dec;12(17):2695-706. doi: 10.1517/14656566.2011.629187. Review.


Beyond cancer vaccines: a reason for future optimism with immunomodulatory therapy.

Postow M, Callahan MK, Wolchok JD.

Cancer J. 2011 Sep-Oct;17(5):372-8. doi: 10.1097/PPO.0b013e31823261db. Review.


Sunitinib facilitates the activation and recruitment of therapeutic anti-tumor immunity in concert with specific vaccination.

Bose A, Taylor JL, Alber S, Watkins SC, Garcia JA, Rini BI, Ko JS, Cohen PA, Finke JH, Storkus WJ.

Int J Cancer. 2011 Nov 1;129(9):2158-70. doi: 10.1002/ijc.25863. Epub 2011 May 25.


Stimulation of the glucocorticoid-induced TNF receptor family-related receptor on CD8 T cells induces protective and high-avidity T cell responses to tumor-specific antigens.

Côté AL, Zhang P, O'Sullivan JA, Jacobs VL, Clemis CR, Sakaguchi S, Guevara-Patiño JA, Turk MJ.

J Immunol. 2011 Jan 1;186(1):275-83. doi: 10.4049/jimmunol.1001308. Epub 2010 Nov 24.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk